<DOC>
	<DOC>NCT01818232</DOC>
	<brief_summary>This phase 1 study is to evaluate the pharmacokinetics (PK), metabolism, routes and extent of elimination of a single oral dose of 400 mg [14C]LX4211 to healthy male subjects</brief_summary>
	<brief_title>Study to Determine the Absorption, Metabolism, and Excretion of [14C]LX4211 in Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Adults ≥18 to ≤55 years of age Vital signs at Screening in the following ranges: systolic blood pressure, 90140 mm Hg; diastolic blood pressure, 5090 mm Hg; heart rate, 50100 bpm Body mass index (BMI) ≥18 and ≤35 kg/sq m Historically able to produce a minimum of 1 bowel movement per day Willing and able to provide written informed consent Female Receipt of any investigational drug within 30 days prior to Dosing, or investigational protein or antibodybased therapeutic agents within 3 months prior to Screening Prior exposure to LX4211 Use any tobacco product within 2 months prior to Screening and while participating in the study (Day 1 through Discharge) History of bariatric surgery or any other GI surgery that may induce malabsorption History of any major surgery within 6 months prior to Screening History of renal or hepatic disease, or significantly abnormal kidney or liver function tests at Screening History of any clinically relevant psychiatric, renal, hepatic, pancreatic, cardiovascular, neurological, hematological, or GI abnormality History of any active infection within 14 days prior to Dosing History of alcohol or substance abuse within 2 years prior to Dosing History of human immunodeficiency virus (HIV), hepatitis B, or hepatitis C Donation or loss of &gt;400 mL of blood or blood product within 3 months of Dosing Positive urine glucose at Screening Positive urine screen for drugs of abuse at Screening or Day 1 Positive breath test for alcohol at Screening or Day 1 Participation in &gt;1 other radiolabeled investigational study drug trial within 12 months prior to Day 1 Exposure to significant radiation within 12 months prior to Day 1</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>